(Reuters) – Eyenovia said on Friday it would terminate a late-stage study testing its experimental drug-device combination for pediatric progressive myopia as it failed to meet the main goal.
(Reporting by Mariam Sunny in Bengaluru; Editing by Shilpi Majumdar)
